ADARX PHARMACEUTICALS
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts. It discovers and develops innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on an mRNA, thus the production of desired and functional protein is restored.
ADARX PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.adarx.com
Total Employee:
11+
Status:
Active
Contact:
(877) 232-7974
Total Funding:
332 M USD
Technology used in webpage:
Google Maps U.S. Server Location
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
NeonMind Biosciences
NeonMind Biosciences is a psilocybin-based drug candidates targeting obesity.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Suplement.io
Suplement.io is a strategic partner creating and supplying eco dietary supplements for businesses.
Current Advisors List
Board_member
2022-07-01
Board_member
2023-08-09
Board_member
2020-01-01
Board_member
2023-08-09
Current Employees Featured
Zhen Li Founder, President & CEO @ ADARx Pharmaceuticals
Founder, President & CEO
Hubert Chen Chief Medical Officer @ ADARx Pharmaceuticals
Chief Medical Officer
2022-01-01
Robert MacLeod Chief Scientific Officer @ ADARx Pharmaceuticals
Chief Scientific Officer
2023-01-01
Chris Storgard Chief Medical Officer @ ADARx Pharmaceuticals
Chief Medical Officer
2024-04-01
Founder
Investors List
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series C - ADARx Pharmaceuticals
SR One
SR One investment in Series C - ADARx Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series C - ADARx Pharmaceuticals
Marshall Wace
Marshall Wace investment in Series C - ADARx Pharmaceuticals
BlackRock
BlackRock investment in Series C - ADARx Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series C - ADARx Pharmaceuticals
HBM Healthcare Investments
HBM Healthcare Investments investment in Series C - ADARx Pharmaceuticals
Redmile Group
Redmile Group investment in Series C - ADARx Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series C - ADARx Pharmaceuticals
T. Rowe Price
T. Rowe Price investment in Series C - ADARx Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.adarx.com
- Host name: 197.46.153.160.host.secureserver.net
- IP address: 160.153.46.197
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ADARx Pharmaceuticals"
Company Overview - ADARx Pharmaceuticals
Corporate Offices 5871 Oberlin Drive, Suite 200 San Diego, CA 92121 info@adarx.com (877) 232-7974 (877) ADARX-PHSee details»
ADARx Pharmaceuticals - Crunchbase Company Profile …
ADARx Pharmaceuticals may be growing as it has successfully secured a significant amount of funding, with $200 million raised in an oversubscribed …See details»
ADARx Pharmaceuticals 2025 Company Profile: …
ADARx Pharmaceuticals is headquartered in San Diego, CA. What is the size of ADARx Pharmaceuticals? ADARx Pharmaceuticals has 47 total employees. …See details»
ADARx Pharmaceuticals - 2025 Company Profile - Tracxn
ADARx Pharmaceuticals - Developer of genetic therapeutic solutions to edit single point mutations on RNA transcripts. Raised a total funding of $353M over 7 rounds from 18 investors. …See details»
ADARx Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
Mar 6, 2025 Explore ADARx Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 21 news, Disease Domain:Immune System Diseases, …See details»
ADARx Pharmaceuticals - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
ADARx Pharmaceuticals - VentureRadar
ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies. …See details»
ADARx Pharmaceuticals - Contacts, Employees, Board Members
Organization. ADARx Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... ADARx Pharmaceuticals has …See details»
Company - ADARx Pharmaceuticals
Corporate Offices 5871 Oberlin Drive, Suite 200 San Diego, CA 92121 info@adarx.com (877) 232-7974 (877) ADARX-PHSee details»
ADARx Pharmaceuticals Inc Overview - Salary.com
ADARx Pharmaceuticals is located in San Diego, California, United States and was established in 2019. They are a biotechnology company committed to turning cutting-edge science into life …See details»
Team - ADARx Pharmaceuticals
Dr. Li is a co-founder of ADARx and a successful executive with more than two decades of diverse experience in research and development in the pharmaceutical and biotech industries. …See details»
ADARx Pharmaceuticals
About: ADARx Pharmaceuticals is a newly launched next-wave genetic medicine company focusing on oligonucleotide therapeutics for inhibition, degradation and base editing of mRNA …See details»
ADARx Pharmaceuticals - Overview, News & Similar companies
ADARx Pharmaceuticals to Participate in the 44th Annual Cowen Healthcare Conference SAN DIEGO--(BUSINESS WIRE)--ADARx Pharmaceuticals, Inc. (ADARx), a clinical stage …See details»
Company: ADARx Pharmaceuticals - crisprmedicinenews.com
ADARx Pharmaceuticals is a clinical-stage biotechnology company focused on developing RNA-targeting therapeutics. The company utilises proprietary oligonucleotide technologies for RNA …See details»
ADARx Pharmaceuticals Company Profile | Management and
ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies. …See details»
ADARx Pharmaceuticals - Bain Capital Life Sciences
ADARx Pharmaceuticals, located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed …See details»
News - ADARx Pharmaceuticals
Sep 8, 2021 Corporate Offices 5871 Oberlin Drive, Suite 200 San Diego, CA 92121 info@adarx.com (877) 232-7974 (877) ADARX-PHSee details»
ADARx Pharmaceuticals - Craft
ADARx Pharmaceuticals is a company developing an RNA-targeting platform for creating therapeutics. It offers an oligonucleotide targeting solution for inhibition, degradation, and …See details»
ADARx Pharmaceuticals - Sirona CapitalSirona Capital
ADARx is developing a modality agnostic RNA targeting platform, including oligonucleotides for inhibition, degradation and editing, together with novel oligonucleotide delivery technologies. …See details»